Brief: Novan Appoints Brian M. Johnson As Chief Commercial Officer And Receives Conditional FDA Acceptance Of Proposed Brand Name KINSOLUS For SB206 In Molluscum Contagiosum
02/11/2021 13:03
Nov 2 (Reuters) - Novan Inc NOVN.O :
* NOVAN APPOINTS BRIAN M. JOHNSON AS CHIEF COMMERCIAL
OFFICER AND
RECEIVES CONDITIONAL FDA ACCEPTANCE OF PROPOSED BRAND NAME
KINSOLUS™ FOR SB206 IN MOLLUSCUM CONTAGIOSUM
Source text for Eikon: ID:nGNX7Mnk5P
Further company coverage: NOVN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on NVN Liquidation
See all newsBrief: Nvn Liquidation Says On April 30, Debtors Filed Notice Of Effective Date With Bankruptcy Court
Brief: Novan Received Notice From Nasdaq Notifying Co's Securities Will Be Delisted From Nasdaq
Brief: Novan Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
U.S. STOCKS ON THE MOVE-Lands' End, Energy sector
U.S. STOCKS ON THE MOVE-Biogen, NetApp, LyondellBasell